Samantha Whitman has extensive experience in the pharmaceutical and biotechnology sectors, holding leadership positions such as Associate Director at Pfizer and Seagen, and serving as Director of Corporate Strategy at NextCure, Inc. Additionally, Samantha has contributed as a Strategic Advisor in Marketing and Translational Sciences at Personal Genome Diagnostics and led business development at Synactix Pharmaceuticals, Inc. Educational qualifications include a Ph.D. in Cell Biology from the University of Arizona and a Master of Science in Exercise Physiology from The University of Kansas.